רספרים

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

متاح من:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC رمز:

J01EE01

الشكل الصيدلاني:

תרחיף

تركيب:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

طريقة التعاطي:

פומי

نوع الوصفة الطبية :

מרשם נדרש

المصنعة من قبل:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

المجموعة العلاجية:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

المجال العلاجي:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

الخصائص العلاجية:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

تاريخ الترخيص:

2012-01-31